Dec. 22, 2017 Price forecast | 2 weeks: 2.36% | 1 month: 2.07% | 3 months: 3.03%


CBMG stock forecast

Our latest prediction for Cellular Biomedicine Group, Inc.'s stock price was made on the Dec. 22, 2017 when the stock price was at 11.10$.

In the short term (2weeks), CBMG's stock price should outperform the market by 2.36%. During that period the price should oscillate between -6.54% and +9.37%.

In the medium term (3months), CBMG's stock price should outperform the market by 3.03%. During that period the price should oscillate between -16.07% and +27.59%.

Create a solid portfolio with CBMG

Add CBMG to your portfolio and optimize it!


About Cellular Biomedicine Group, Inc.

Cellular Biomedicine Group, Inc. is a holding company, which engages in the development of new treatments for cancerous and degenerative diseases utilizing proprietary cell-based technologies. It specializes in immune cell therapy. The company was founded in 2009 and is headquartered in New York, NY.

At the moment the company doesn't generate any revenue.

On its last earning announcement, the company reported a loss of -2.24$ per share.

The book value per share is 4.18$

Cellular Biomedicine Group, Inc. website


Three months stock forecastDec. 22, 2017


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
- 45.50% -35M - -37M -2.24 - - 17M 4.18 -24M -10M -34M